Back to Journals » Breast Cancer: Targets and Therapy » Volume 15
Original Research
Differences in Treatment Outcomes Between Patients with HER2-Low versus HER2-Zero, Hormone Receptor-Positive Advanced-Stage Breast Cancer Treated with Ribociclib
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
2,895 | Dovepress* | 2,669+ | 73 | 2,742 | |
PubMed Central* | 226 | 79 | 305 | ||
Totals | 2,895 | 152 | 3,047 | ||
*Since 28 July 2023 |
View citations on PubMed Central and Google Scholar